Biosimilars in treatment of multiple sclerosis in Iran
Hossein Pakdaman
Balram Pani, Pooja Gupta, Ranjeet S Thakur, Avneesh Mittal, Purnima Anand, Deepika Bhaskar and Uma Chaudhry
Emerging biosimilars in the USA – Quo vadis?
Melissa Law
Dipti Gulati
Evolution of structure-function paradigm in biopharmaceutics based on global regulatory needs
Dinesh Palanivelu
Using IPRs in the biosimilars context
Laura Burson
Takashi Shimada
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report